A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy
Giorgio Maria Saracco(Ospedale Maggiore), Enrico Roda(Ospedale Maggiore), V. Lattore(Ospedale Maggiore), G. Mazzella(University of Bologna), C. Cancellieri(Ospedale Maggiore), Giorgio Verme(Ospedale Maggiore), Floriano Rosina(Ospedale Maggiore), Enzo Raise(Ospedale Maggiore), Mario Rizzetto(University of Turin), Luigi Barbara(Ospedale Maggiore), Giovanni Gasbarrini(University of Milan), Laura M. Giorda(Ospedale Maggiore), Giuseppe Rocca(Ospedale Maggiore), Ferruccio Bonino(Ospedale Santa Chiara)
Cited by 86
Related Papers
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
|Hepatology|2003|2.7k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
|Diabetologia|2005|759
Bone mass and metabolism in patients with celiac disease
|Gastroenterology|1995|236